NanoSignal Corp. Announces Marketing Agreement with Cell Robotics International Inc

Business Wire, Dec 1, 2005

LAS VEGAS -- NanoSignal Corp., an OTC Pink Sheets Fully Reporting Company, symbol (NNOS), announced today that it has entered into an international marketing agreement with Cell Robotics International Inc. (CRII) to market its Lasette(R) products worldwide.

Under the agreement, NanoSignal will have an exclusive right to promote and market Cell Robotics International's products in Central and South America, and non-exclusive rights in an additional 150 countries. NanoSignal is developing strategic alliances with other companies that manufacture and/or market medical products. "This agreement with CRII, these strategic alliances, and the right to market NanoSignal's "Slices" technology will greatly increase the worth of a NanoSignal franchise," said Kelly Slade, president and CEO of NanoSignal. Under a previous announcement, NanoSignal announced its relationship with FranTech International, which will market the NanoSignal franchise worldwide.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements can be identified by the lead-in "Looking Forward." This statement is not a guarantee of future sales of products or franchises, and involves significant risks and uncertainties. Actual results may vary materially from those in the forward-looking statement.